688067 Ave Science&Technology
- 13.27
- +0.21+1.61%
Ave Science&Technology News
Aiwei Technology 2024 Semi-Annual Report
Summary of Aiwei Technology\'s 2024 Semi-Annual Report
iwee Technology (688067.SH): net income of 11.6003 million yuan in the first half of the year, a year-on-year increase of 24.19%.
Aiwu Technology (688067.SH) released its semi-annual report on August 28th. The company achieved a total operating revenue of 97.1952 million yuan, a year-on-year increase of 2.63%. The net income attributable to shareholders of the listed company was 11.6003 million yuan, a year-on-year increase of 24.19%. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 8.2954 million yuan, a year-on-year increase of 100.97%.
Aibei Technology (688067.SH) repurchased 0.025 million shares of the company's stock for the first time.
Gelonghui, August 5, 丨 Aiwei Technology (688067.SH) announced that on August 5, 2024, the company repurchased 25,000 shares of the company's shares for the first time through centralized bidding transactions, accounting for 0.0368% of the company's total share capital. The highest price of the repurchase transaction was 13.90 yuan/share, the lowest price was 13.47 yuan/share, and the total transaction amount was RMB 341,769.33 (excluding transaction fees such as stamp duty and transaction fees).
Aiwake Technology (688067.SH) has not yet implemented stock buybacks.
On July 31, Gelunhui announced that Iwic Technology (688067.SH) has not yet implemented stock repurchases as of July 31, 2024.
Express News | Nearly 10 listed companies have disclosed announcements of repurchase or shareholding plans after the market close. Jiangsu Wanlin Modern Logistics plans to repurchase up to 0.3 billion yuan and use it for cancellation.
Express News | iWEI Technology: plans to repurchase shares for 10-20 million yuan.
Express News | Aiwu Technology: Received a proposal from the company's actual controller and chairman to repurchase company shares.
Aiwake Technology (688067.SH) will distribute a cash dividend of 0.1 yuan per share for the year 2023 on July 4.
Aiwu Technology (688067.SH) announced that it will issue the annual dividend for 2023 on July 4th, 2024...
Express News | A list of restricted stocks in A-shares to be released: 28.819 billion yuan Market Cap restricted stocks will be released today.
Zeng Tengfei, the secretary of the board of directors of Aiweike Technology (688067.SH), resigned.
The AIWEI Technology (688067.SH) has announced that the board of directors of the company has recently received the resignation report of Mr. Zeng Tengfei, the company's board secretary, due to personal reasons. Mr. Zeng Tengfei's resignation report shall take effect upon delivery to the board of directors. After his resignation, Mr. Zeng Tengfei will no longer hold any position in the company.
Aiwu Technology (688067.SH): 26.9829 million shares of restricted shares will be listed for circulation from June 17, accounting for 39.68% of the total share capital.
AIWAYS Technology (688067.SH) announced that the company has released restricted shares and applied for the listing of tradable shares...
Aiwei Technology (688067.SH): Net profit for the first quarter was 5.0718 million yuan, up 136.42% year on year
Gelonghui, April 26 | Aiwei Technology (688067.SH) released its report for the first quarter of 2024. During the reporting period, it achieved operating income of 468.13,800 yuan, an increase of 14.46% over the previous year; net profit attributable to shareholders of listed companies was 5.0718 million yuan, an increase of 136.42%; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 3.3656 million yuan; and basic earnings per share were 0.07 yuan.
Aiwei Technology (688067.SH): The company's Helicobacter pylori test reagents did not involve C-14
Gelonghui, April 23 | Aiwei Technology (688067.SH) said on the investor interactive platform that the company's Helicobacter pylori test reagent did not involve C-14, and its localization had no impact on the company.
AVE Science&Technology CO.,LTD's (SHSE:688067) Shares Climb 27% But Its Business Is Yet to Catch Up
Aiwei Technology (688067.SH): Net profit increased 21.23% year-on-year in 2023
Gelonghui, Feb. 27丨Aiwei Technology (688067.SH) announced its 2023 annual performance report. In 2023, the company achieved operating income of 20,047.88 million yuan, an increase of 1.88% year on year; achieved net profit attributable to owners of the parent company of 21.784 million yuan, an increase of 21.23% year on year; realized net profit attributable to owners of the parent company after deducting non-regular profit and loss of 11.8705 million yuan, an increase of 89.25% year on year. At the end of the reporting period, the company's total assets were 55,703.51 million yuan, up 1.34% from the beginning of the reporting period; owned by the parent company
Some AVE Science&Technology CO.,LTD (SHSE:688067) Shareholders Look For Exit As Shares Take 26% Pounding
688067.SH () released the first three quarter results, net profit of 24.1 million yuan, up 1.01% year on year
688067.SH () disclosed its report for the third quarter of 2023. The company achieved revenue of 1 in the first three quarters...
Aiwei Technology (688067.SH) reported a semi-annual net profit of 9.340,800 yuan, a year-on-year decrease of 21.82%
Glonghui, August 29丨Aiwei Technology (688067.SH) disclosed the 2023 semi-annual report, achieving operating income of 9470.1 million yuan, up 1.31% year on year; net profit attributable to shareholders of listed companies was 9.340,800 yuan, down 21.82% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 4.1276 million yuan, down 37.45% year on year; basic earnings per share were 0.14 yuan.
Aiwei Technology (688067.SH): The raw materials of the company's instruments and consumables products are mostly purchased from outside
GLONGHUI July 31 | Aiwei Technology (688067.SH) recently said in response to research from institutional investors that the company's instruments and consumables are mostly purchased from outside. In terms of reagent products, the company has set up a dedicated R&D team to carry out research and development of antigen antibodies and other related raw materials, gradually realizing its own production of raw materials for the company's reagent products.
Analysis
Price Target
No Data
